A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Trial Profile

A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 May 2013

At a glance

  • Drugs Sunitinib (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 19 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 24 Jun 2010 Planned end date changed from 1 Jul 2012 to 1 Aug 2012 as reported by ClinicalTrials.gov.
    • 12 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top